title: [Multisite validation of CDT measurement by the %CDT TIA and the Tina Quant %CDT kits].
abstract: The measurement of CDT (Carbohydrate Deficient Transferrin) is an essential biological tool in the diagnosis and follow-up of alcohol abuse. It is also employed as a marker of abstinence for the restitution of driving licences. However, the precision of measurement, and the between laboratory homogeneity of the results are still discussed. The ion exchange followed by immunodetermination of CDT is available in two products, the Tina Quant %CDT (Roche, Mannheim, Germany) and the %CDT TIA (Bio-Rad, Hercules, United States). This multicentre study was undertaken: 1) to evaluate the analytical characteristics of these kits and the homogeneity of the results from one laboratory to another, independently of the method used, 2) to validate the differences between the proposed normal values of both kits, 3) to study the possibility of using commercial control sera as external quality control. Four analytical systems were included in the study (Roche Modular/Hitachi 717, Beckman Coulter Immage and LX20, Dade Behring BNII). Determinations were carried out on pools of sera, commercial control sera, kit controls, and 30 serums of patients. These latter were also analyzed in capillary electrophoresis in order to establish correlations between the techniques. The calibrations were stable over one 2 weeks period. The repeatability of measurements spread out from 3,1% to 24,7%, for a mean value lower than 10%. The commercial control sera provided reliable results, with values adapted to a routine quality control use. The results of the Bio-Rad applications were lower by approximately 20% than those of the Roche application, which justifies the difference of the normal values (2,6% versus 3%), and an identical classification of the patients in at least 27 of the 30 samples. We conclude that the analytical quality of the compared techniques, even if it could be improved, is sufficient to guarantee a good reliability of the results. An external quality control could be proposed by using the control sera that we tested.
authors.affiliation: Centre hospitalier de Haguenau.
authors.forename: J L
authors.initials: JL
authors.lastname: Boehrer
authors.forename: Y
authors.initials: Y
authors.lastname: Cano
authors.forename: B
authors.initials: B
authors.lastname: Capolaghi
authors.forename: G
authors.initials: G
authors.lastname: Desch
authors.forename: I
authors.initials: I
authors.lastname: Dosbaa
authors.forename: L
authors.initials: L
authors.lastname: Estepa
authors.forename: B
authors.initials: B
authors.lastname: Hennache
authors.forename: F
authors.initials: F
authors.lastname: Schellenberg
mesh_terms: D006801:Humans; D011933:Reagent Kits, Diagnostic; D014168:Transferrin / Q000031:analogs & derivatives* / Q000032:analysis
chemical_list: D011933:Reagent Kits, Diagnostic; D014168:Transferrin; C056759:carbohydrate-deficient transferrin